Skip to main content
OpenTrials
Completed

NCT Number: NCT01940822

Cardiovascular Effects of Energy Drinks in Healthy Adults

This study is being done to look at the cardiovascular response, if any, to intake of commercially available energy drink. We hypothesize that energy drink consumption compared to a control drink in healthy adults alters the cardiovascular hemodynamic system.The focus of this study is to elucidate the physiological/cardiovascular response to an energy drink consumption as compared to a control drink both at rest and during stressful conditions in healthy adults.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

About this study

The study will collect data to determine the hemodynamic changes (magnitude of heart rate and blood pressure response) in healthy adults after consumption of an energy drink and compare these responses to those after a control drink. Study will be performed at a hospital Clinical Research Unit on two separate days; minimum 24 hours and maximum 1 month apart. Participants will be fasting 4 hours prior to the study and will be asked to abstain from caffeine and alcohol for at least 24 hours prior to initiation of this study. Baseline measurements will be obtained during and after 10 minutes of rest. After the end of baseline recordings, the subjects will be given up to 500 ml (1 can, approximately 16 fluid ounces) of caffeinated energy drink or a control drink, based on randomization. They will have 30 minutes to drink it. The second set of measurements will be obtained after an energy drink or control drink intake, using exactly the same protocol as at baseline. The second study visit, participant will receive the alternate intervention.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults 18 years of age and older
  • Healthy subjects without known cardiovascular disease and thyroid disease
  • Subjects who are on no medications (except oral contraceptive pill)
  • Nonsmokers
  • No prior history of caffeine sensitivity or allergy

Exclusion criteria

  • Subjects with known cardiovascular and/or thyroid disease
  • Subjects currently taking medications other than oral contraceptive pill
  • Smokers
  • Prior history of caffeine sensitivity or allergy
  • Pregnancy

Treatment and study plan

Energy drink

Other

Placebo drink

Other

Primary outcomes

  1. Change in blood pressure

    Time frame: Baseline, 30 minutes after consumption

Secondary outcomes

  1. Change in heart rate

    Time frame: Baseline, 30 minutes after consumption

  2. Change in Plasma Norepinephrine

    Time frame: Baseline, 30 minutes after consumption

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Sep 12, 2013
Registry last updated
May 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.